The effect of metformin treatment to ovarian response in cases with PCOS
Tasdemir, S.; Ficicioglu, C.; Yalti, S.; Gurbuz, B.ül.; Basaran, T.; Yildirim, G.
Archives of Gynecology and Obstetrics 269(2): 121-124
2004
ISSN/ISBN: 0932-0067 PMID: 12764624 DOI: 10.1007/s00404-002-0447-8Document Number: 261170
To examine the effect of metformin therapy on ovarian response in clomiphene-resistant PCOS patients. Randomized prospective study. Zeynep Kamil Hospital IVF Center. Thirty-two female PCOS patients with clomiphene citrate resistance. Test group A received 2x850 mg/day metformin therapy for 8 weeks, followed by gonadotropin induction. Only gonadotropin induction was applied to Control group B. Total gonadotropin dosage, duration of gonadotropin therapy, estradiol level on HCG-day, number of follicles with >or=16 mm diameter, number of cases with hyperstimulation development, number of cancelled cycles, endometrial thickness on HCG-day, pregnancy outcome, multiple pregnancy rate. The total gonadotropin doses given to metformin-study group was significantly lower than the control group. In addition, duration of therapy, HCG level, plasma estradiol level on HCG-day in the study group was significantly lower than in the control group. Metformin therapy has led to a higher pregnancy outcome, as well as to a decrease in hyperstimulation risk, cycle cancellations, and multiple pregnancy rates with a lower gonadotropin dosage.
Document emailed within 0-6 h
